- Home
- NCA vs DRTS Comparison
NCA vs DRTS Comparison
Compare NCA & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCA
- DRTS
- Stock Information
- Founded
- NCA 1987
- DRTS 2015
- Country
- NCA United States
- DRTS Israel
- Employees
- NCA N/A
- DRTS N/A
- Industry
- NCA Investment Managers
- DRTS Medical/Dental Instruments
- Sector
- NCA Finance
- DRTS Health Care
- Exchange
- NCA Nasdaq
- DRTS Nasdaq
- Market Cap
- NCA 278.1M
- DRTS 262.6M
- IPO Year
- NCA N/A
- DRTS N/A
- Fundamental
- Price
- NCA $8.48
- DRTS $3.00
- Analyst Decision
- NCA
- DRTS Strong Buy
- Analyst Count
- NCA 0
- DRTS 2
- Target Price
- NCA N/A
- DRTS $8.00
- AVG Volume (30 Days)
- NCA 59.6K
- DRTS 39.8K
- Earning Date
- NCA 01-01-0001
- DRTS 08-13-2025
- Dividend Yield
- NCA 3.92%
- DRTS N/A
- EPS Growth
- NCA N/A
- DRTS N/A
- EPS
- NCA N/A
- DRTS N/A
- Revenue
- NCA N/A
- DRTS N/A
- Revenue This Year
- NCA N/A
- DRTS N/A
- Revenue Next Year
- NCA N/A
- DRTS N/A
- P/E Ratio
- NCA N/A
- DRTS N/A
- Revenue Growth
- NCA N/A
- DRTS N/A
- 52 Week Low
- NCA $7.77
- DRTS $1.75
- 52 Week High
- NCA $9.12
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- NCA 52.29
- DRTS 52.88
- Support Level
- NCA $8.41
- DRTS $2.85
- Resistance Level
- NCA $8.48
- DRTS $3.10
- Average True Range (ATR)
- NCA 0.08
- DRTS 0.19
- MACD
- NCA 0.00
- DRTS -0.02
- Stochastic Oscillator
- NCA 45.00
- DRTS 37.33
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.